ID Epi Seminar Series Videos

ID Epi Seminar Series 2020


January 30: Disease in motion in Madagascar.
C. Jessica E. Metcalf
, Department of Ecology and Evolutionary Biology, Woodrow Wilson School, Princeton University

February 6: Estimating infectious disease parameters for tuberculosis in Massachusetts using a novel method to link cases.
Sarah Leavitt
, MA, Department of Biostatistics at Boston University

February 13: Optimization of laboratory technology for HIV/TB diagnostics in sub-Saharan Africa: an integrated modeling approach.
Brooke Nichols,
Assistant Professor, Department of Global Health, Boston University School of Public Health

February 20: Modeling the dynamics of Malaria infection.
Lauren Childs, Assistant Professor, Department of Mathematics, Virginia Tech

February 27: Forget flu: how about a universal norovirus vaccine?
Benjamin Lopman, Professor, Department of Epidemiology, Rollins School of Public Health, Emory University

ID Epi Seminar Series 2019


February 7: Evolutionary constraints in influenza and their consequences for viral cooperation and conflict. Katia Koelle, PhD, Assistant Professor, Department of Biology, Emory University

February 14: Infectious disease surveillance using routine laboratory data: Building a novel platform for research on South Africa’s HIV and TB epidemics. Jacob Bor, SD, Assistant Professor, Departments of Global Health and Epidemiology, Boston University School of Public Health

February 21: Influenza vaccine research in the international setting: Trials, tribulations and lessons learned. Kathleen Neuzil, MD, MPH, FIDSA, FACP, Director, Center for Vaccine Development and Global Health, Director, Division of Geographic Medicine, Professor, Medicine and Pediatrics, University of Maryland School of Medicine

February 28:
Will original antigenic sin hinder the generation of a “universal” influenza vaccine? Rustom Antia, PhD, Professor, Department of Biology, Emory University

March 7: Influenza virus evolution, getting personal. Adam Lauring, MD, PhD, Associate Professor, Division of Infectious Diseases, Department of Microbiology & Immunology, University of Michigan

March 14: Gut microbiome dynamics during bone marrow transplantation: Revelations for the rest of us. Ying Taur, MD, MPH, Assistant Professor, Infectious Diseases, Memorial Sloan Kettering Cancer Center, Department of Medicine, Infectious Diseases Service


March 28: Technological innovation in public health: CDC’s advanced molecular detection program. Duncan MacCannell, Chief Science Officer, Office of Advanced Molecular Detection, CDC

April 4: Inferring hospital transmission and antibiotic resistance evolution of a multi-drug resistant hospital pathogen. Robert Woods, MD, PhD, Assistant Professor, University of Michigan Medical School, Division of Infectious Diseases

April 11: Applying the test negative design to evaluate vaccine effectiveness during outbreaks. Natalie Dean, PhD, Assistant Professor, Department of Biostatistics, University of Florida

April 18: Characterizing the global emergence of arboviruses. Isabel Rodriguez-Barraquer, MD, PhD, Assistant Professor, Division of HIV, ID and Global Medicine, Department of Medicine, University of California

May 2: Designing pneumococcal vaccines with ecological modeling and genomic data. Caroline Colijn, Canada 150 Research Chair, Simon Fraser University

May 9: Complex networks and P. falciparum: from evolution to epidemiology. Daniel Larremore, Assistant Professor, Department of Computer Science & BioFrontiers Institute, University of Colorado

May 16: Drug resistance evolution in malaria: CRISPR, crosses and more! Tim Anderson, Program lead, Disease Intervention and Prevention, Texas Biomedical Research Institute

ID Epi Seminar Series 2018


May 10, 2018: Surveilling the gut bacterial pathogen landscape: Insights into multi-drug resistance. Anne-Catrin Uhlemann, MD, PhD, Florence Irving Assistant Professor of Medicine, Division of Infectious Diseases, College of Physicians and Surgeons at Columbia University

May 3, 2018: Building a better public private partnership for biosecurity: lessons from the coalition for epidemic preparedness innovations. Kendall Hoyt, PhD, Assistant Professor, Geisel School of Medicine, Dartmouth University

April 26, 2018: Immune driven pathogen evolution. Sunetra Gupta, PhD, Professor of Theoretical Epidemiology, Department of Zoology, University of Oxford

March 29, 2018:  Why has dengue resurged, why does malaria persist, and can these diseases be controlled by CRISPR-based gene drive and other novel tools? John Marshall, PhD, Assistant Professor in Residence, Biostatistics and Epidemiology, University of California, Berkeley, School of Public Health

March 22, 2018: Friend or Foe?: Immune responses to dengue and Zika Viruses. Eva Harris, PhD, Professor, Division of Infectious Diseases and Vaccinology, and Director of the Center for Global Public Health, University of California, Berkeley, School of Public Health

March 8, 2018: What is required to end AIDS as a public health threat by 2030? John Stover, Vice President and founder, Avenir Health

March 1, 2018: On the predictability of infectious disease outbreaks. Samuel Scarpino, PhD, Assistant Professor of Marine & Environmental Sciences and Physics, Northeastern University

February 22, 2018:  The incidence, etiology, and clinical sequelae of diarrheal diseases in African children before and after rotavirus vaccine introduction. Karen Kotloff, MD, Head of the Division of Infectious Disease and Tropical Pediatrics, and Associate Director of Clinical Studies at the Center for Vaccine Development, University of Maryland School of Medicine

February 15, 2018: Why biofilm growth can generate fundamentally different dynamics and mechanisms of antimicrobial resistance. Vaughn Cooper, PhD, Associate Professor, Department of Microbiology and Molecular Genetics, University of Pittsburgh